Metabotropic glutamate receptor 5: a target for migraine therapy.

Waung, Maggie W; Akerman, Simon; Wakefield, Mark; Keywood, Charlotte; Goadsby, Peter J

Waung, Maggie W; Akerman, Simon; Wakefield, Mark; Keywood, Charlotte; Goadsby, Peter J.

Afiliación

Waung MW; Department of Neurology University of California, San Francisco San Francisco California.
Akerman S; Department of Neurology University of California, San Francisco San Francisco California; Present address: Department of Oral and Maxillofacial Pathology, Radiology and Medicine New York University College of Dentistry New York City New York.
Wakefield M; Addex Pharma Geneva Switzerland; Present address: Outsourcing Management (Ext)Oncology Business Unit Novartis Pharma AGPostfach CH-4002 Basel Switzerland.
Keywood C; Addex Pharma Geneva Switzerland; Present address: Minerva Pharmaceutical Consulting Ltd London United Kingdom.
Goadsby PJ; Department of Neurology University of California, San Francisco San Francisco California; Basic and Clinical Neurosciences Institute of Psychiatry, Psychology and Neuroscience Kings College London London United Kingdom.

Ann Clin Transl Neurol ; 3(8): 560-71, 2016 08.

Article en En | MEDLINE | ID: mdl-27606340

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Ann Clin Transl Neurol Año: 2016 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google